Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLombard Risk Management Regulatory News (LRM)

  • There is currently no data for LRM

Regulatory Contracts Won

13 Jan 2010 07:00

RNS Number : 4374F
Lombard Risk Management PLC
13 January 2010
Β 

ο»Ώ

LOMBARD RISK MANAGEMENT WINS SIX REGULATORY CONTRACTS IN UK

London, 13thΒ January 2010

Lombard Risk Management plc, ("Lombard Risk"Β or the "Company") the global provider of specialisedΒ software solutions that improve the management of collateralised trading, liquidity and regulatory compliance, has won its first regulatory contract of 2010. This takes to sixΒ theΒ total of contracts wonΒ by Lombard RiskΒ for UK regulatory reporting in the last two months. These six contracts have a total first year value of over Β£500,000. Some of the revenue from these contracts will be recognized in the current financial year, but owing to theΒ Company'sΒ revenue recognition policy the majority will be recognized in the financial year to March 2011. One of these six firms is a new client, and the others are existing bank and building society clients of Lombard Risk for regulatory reporting who are expanding the scope of their contracts to include the new Liquidity Standards finalized by the FSA in October 2009. Four of these clients' contracts include signing up at the same time for Lombard Risk's liquidity stress testing software.

John Wisbey, CEO of Lombard Risk commented

"We are very pleased to have won the business of another new client in the UK and the further business of a number of UK banks and building societies that already use us for their FSA regulatory reporting in the UK in which we are the market leader. We have many more customers who will be making decisions shortly, and we believe they will take great comfort from the fact that our software delivery is on track and that we have closely integrated solutions both for the liquidity regulatory reporting element and for the associated liquidity stress testing and scenario analysis. The latter, which is going to be required by the FSA and other international regulators, is in any case prudent liquidity risk management and therefore helps with good management of a bank as well as in complying with regulations."

Β "In a world of increasing financial regulation, some of the world's top banks rely on Lombard Risk to report to regulators and to monitor and manage their risk. Our products in Collateral Management, Liquidity and Regulatory Compliance are all increasingly complementary as banks and regulators alike look in ever more similar ways at counterparty risk, liquidity and collateral flows".Β 

"The Company is at an exciting position in its development. Following the capital raising in OctoberΒ 2009, our platform for growth is excellent. We are investing in accelerating the growth of the business. We are confident that we will be able to update shareholders on further new contract wins shortly."

Note to EditorsΒ 

The FSA's Liquidity Standards initiative as outlined in the FSA's policy statement PS 09/16* affects all banks in the UK. Other than those banks able to obtain a modification or waiver from the FSA, which means many foreign bank branches in the UK, all UK banks and building societies and many investment firms will need to spend money on complying with the new Liquidity Standards regulations.Β PS09/16 can be found onΒ http://www.fsa.gov.uk/pages/Library/Policy/Policy/2009/09_16.shtml

-ends-

For further information please contact:

Lombard Risk Management plcΒ 

John Wisbey, Chairman and Chief ExecutiveΒ 

Keith Butcher, Finance Director

Tel: 020-7089-3700Β 

Noble & Company LimitedΒ 

John Llewellyn-Lloyd

Sam Reynolds

Tel: 020-7763-2200

City ProfileΒ 

Simon Courtenay

Tel: 020-7448-3244

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTLLFVRLVIFLII
Date   Source Headline
3rd Dec 20141:41 pmRNSExercise of Options
21st Nov 20141:08 pmRNSCollaboration Agreement
11th Nov 201412:19 pmRNSDirector/PDMR Shareholding
16th Oct 20147:00 amRNSHalf Yearly Report
29th Sep 20147:00 amRNSNotice of Results
15th Sep 20144:36 pmRNSDirector/PDMR Shareholding
1st Sep 20147:00 amRNSDirectorate Change
8th Aug 20149:57 amRNSHolding(s) in Company
9th Jul 20143:00 pmRNSResult of AGM
9th Jul 20147:00 amRNSDirectorate Change
9th Jul 20147:00 amRNSAGM Statement
20th Jun 20148:26 amRNSHolding(s) in Company
13th May 20147:00 amRNSFinal Results
16th Apr 20147:00 amRNSTrading Update
2nd Apr 20147:00 amRNSNotice of Results
13th Mar 20148:00 amRNSStrategic Alliance
13th Feb 20147:00 amRNSDirectorate Change
4th Feb 201411:39 amRNSDirector/PDMR Shareholding
31st Jan 20144:02 pmRNSTotal Voting Rights
24th Jan 201412:01 pmRNSIssue of Equity
2nd Jan 20143:29 pmRNSTotal Voting Rights
20th Dec 20138:03 amRNSContract Win
29th Nov 20135:05 pmRNSIssue of Equity
27th Nov 20132:00 pmRNSIssue of Equity
13th Nov 20137:00 amRNSDirectorate Change
5th Nov 201311:44 amRNSTotal Voting Rights
4th Nov 20137:00 amRNSHolding(s) in Company
18th Oct 20135:06 pmRNSDividend Declaration
15th Oct 20137:00 amRNSHalf Yearly Report
10th Oct 20137:00 amRNSProspective contract win
2nd Oct 20137:00 amRNSIssue of Equity
26th Sep 20137:00 amRNSNotice of Results
30th Aug 20137:00 amRNSTotal Voting Rights
19th Aug 20131:30 pmRNSIssue of Equity
19th Aug 201311:30 amRNSDirector/PDMR Shareholding
15th Aug 20137:00 amRNSBoard Changes
14th Aug 20134:35 pmRNSHolding(s) in Company
14th Aug 20133:54 pmRNSDirector/PDMR Shareholding
31st Jul 201310:26 amRNSTotal Voting Rights
19th Jul 20138:45 amRNSHolding(s) in Company
18th Jul 20134:08 pmRNSHolding(s) in Company
18th Jul 20132:20 pmRNSHolding(s) in Company
12th Jul 20134:00 pmRNSResult of AGM
12th Jul 20137:01 amRNSAGM Statement
12th Jul 20137:00 amRNSIssue of Equity
10th Jul 20137:00 amRNSContract Win
8th Jul 20137:00 amRNSBoard Changes
8th Jul 20137:00 amRNSContract Win
28th Jun 20138:49 amRNSTotal Voting Rights
25th Jun 20137:00 amRNSContract with large UK mutual business group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.